SEC Form 4 · accession 0001235802-19-000022
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lance A Berry
Officer — EVP, CFO & Operations Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF2,F3 | Mar 1, 2019 | M | 6,575 | $15.01 | A | 131,784 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF4,F3 | Mar 1, 2019 | S | 6,575 | $31.4256 | D | 125,209 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $15.01 | Mar 1, 2019 | M | 6,575 | D | — | May 13, 2019 | Ordinary Shares | 6,575 | 0 | D |
Explanation of responses
- F1Under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, the reporting person exercised this option, and sold the underlying shares, because the option was in the money and scheduled to expire on May 13, 2019.
- F2The amount in this column was decreased by two shares from the reporting person's previous Form 4 reports due to a clerical error.
- F3Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.35 to $31.55, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- F5This option has fully vested.